Physician profile
David Poulad
NPI 1184695090
$9,062.30
in general payments reported to CMS, 2019-2025
38 companies · $968 in 2025
The $968 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,329 · 2020: $655 · 2021: $925 · 2022: $1,172 · 2023: $2,969 · 2024: $1,044 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,520 · Travel and Lodging: $1,459 · Entertainment: $2.60.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,519.66 |
| Travel and Lodging | $1,459.36 |
| Entertainment | $2.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,941.65 | 2022-2023 | Other - Miscellaneous, Invictus Mis, Solus Alif |
| Stryker Corporation | $2,900.94 | 2019-2025 | Serrato, Monterey Al, Ozark Cervical Plate System |
| Providence Medical Technology, INC. | $370.78 | 2024-2025 | |
| Vb Spine LLC | $296.18 | 2025 | Ozark Cervical Plate System, Everest Spinal System, Aviator |
| Intrinsic Therapeutics | $266.83 | 2022 | |
| Augmedics INC. | $226.60 | 2024-2025 | Xvision |
| Abbott Laboratories | $213.87 | 2019-2021 | |
| Royal Biologics, INC. | $169.97 | 2019-2022 | |
| Medtronic USA, INC. | $169.78 | 2019-2020 | |
| Si-Bone, INC. | $155.24 | 2019-2020 | |
| Nuvasive, INC. | $143.82 | 2019-2020 | |
| Depuy Synthes Sales INC. | $100.82 | 2019-2021 | |
| Spine Wave, INC. | $97.01 | 2019 | |
| Zynex Medical, INC. | $89.08 | 2025 | Nexwave |
| Boston Scientific Corporation | $75.70 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $73.46 | 2022 | |
| Medtronic, INC. | $70.59 | 2021 | |
| Spinal Elements, INC. | $68.08 | 2024-2025 | |
| Surgalign Spine Technologies, INC. | $57.69 | 2019 | |
| Zimvie INC. | $56.19 | 2022 | |
| Portola Pharmaceuticals, LLC | $55.62 | 2019 | |
| Baxter Healthcare | $52.16 | 2024 | Floseal |
| Davol INC. | $50.92 | 2025 | Channel Drain |
| Biotronik Nro, INC. | $41.49 | 2024-2025 | Prospera |
| Stimwave Technologies Incorporated | $38.84 | 2020 | |
| Nevro Corp. | $31.46 | 2021 | |
| Centinel Spine, LLC | $29.44 | 2023 | Prodisc C Vivo |
| Abbvie INC. | $28.84 | 2022-2023 | |
| Vertos Medical, INC. | $28.46 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $28.37 | 2023 | Seglentis |
| Sanara Medtech INC. | $26.08 | 2025 | Celleraterx |
| Zimmer Biomet Holdings, INC. | $19.01 | 2020 | |
| Relievant Medsystems, INC. | $18.72 | 2020 | |
| Scilex Pharmaceuticals INC. | $15.30 | 2023 | Ztlido |
| Clearpoint Neuro, INC. | $14.95 | 2025 | Clearpoint |
| Biohaven Pharmaceuticals, INC. | $14.42 | 2021 | |
| Alexion Pharmaceuticals, INC. | $12.82 | 2022 | |
| Spineology INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Poulad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.